Sex and estrogens alter the action of glucagon-like peptide-1 on reward

被引:64
|
作者
Richard, Jennifer E. [1 ]
Anderberg, Rozita H. [1 ]
Lopez-Ferreras, Lorena [1 ]
Olandersson, Kajsa [1 ]
Skibicka, Karolina P. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, SE-40530 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Glucagon-like peptide-1; GLP-1; Exendin-4; Reward; Estrogens; Sex; Obesity; STRIATAL DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; BETA MESSENGER-RNA; FOOD-INTAKE; RECEPTOR-ALPHA; ADIPOSE-TISSUE; GLUCAGON-LIKE-PEPTIDE-1; RECEPTOR; GONADAL-HORMONES; RAT HYPOTHALAMUS; CENTRAL LEPTIN;
D O I
10.1186/s13293-016-0059-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Feeding behavior is regulated through an intricate array of anorexic and orexigenic hormones acting on the central nervous system (CNS). Some of these hormones may have differential effects in males and females, effects potentially attributed to actions of gonadal steroids, especially estrogens. Central stimulation of the glucagon-like peptide-1 (GLP-1) receptors reduces feeding and food-reward behavior by acting on CNS regions important for the anorexic actions of estrogens. Thus, we propose that the action of GLP-1 on food intake and reward may differ between sexes. Methods: Male and female rats were centrally injected with the GLP-1 analog exendin-4 (Ex4) in a non-deprived or food-restricted state; reward behavior was measured in a progressive ratio operant conditioning task. Intake of chow and palatable food were also measured. To determine if sex differences in the actions of Ex4 are due to interactions with estrogens, Ex4 treatment was preceded by treatment with a nonselective estrogen receptor-a (ER alpha) and ER beta or ER alpha-selective antagonist. Results: Central injection of Ex4 revealed increased reward behavior suppression in females, compared to males, in the operant conditioning task. This increase was present in both non-deprived and food-restricted animals with larger differences in the fed state. Intake of chow and palatable food, after Ex4, were similar in males and females. Food reward, but not food intake, effect of Ex4 was attenuated by pretreatment with ER antagonist in both sexes, suggesting that estrogens may modulate effects of Ex4 in both sexes. Furthermore, central pretreatment with ER alpha-selective antagonist was sufficient to attenuate effects of Ex4 on reward. Conclusions: Collectively, these data reveal that females display much higher sensitivity to the food reward impact of central GLP-1 receptor activation. Surprisingly, they also demonstrate that central ER alpha signaling is necessary for the actions of GLP-1 on food-reward behavior in both sexes.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor agonists in neoplastic diseases
    Ji, Lisan
    He, Xianzhen
    Min, Xinwen
    Yang, Handong
    Wu, Wenwen
    Xu, Hao
    Chen, Jun
    Mei, Aihua
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [42] Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy
    Wen, Yuetao
    Wu, Kunlun
    Xie, Yanfeng
    Dan, Wei
    Zhan, Yan
    Shi, Quanhong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (01) : 79 - 86
  • [43] Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
    Bu, Tong
    Sun, Ziyan
    Pan, Yi
    Deng, Xia
    Yuan, Guoyue
    DIABETES & METABOLISM JOURNAL, 2024, 48 (03) : 354 - 372
  • [44] Treatment of diabetes with glucagon-like peptide-1 gene therapy
    Riedel, Michael J.
    Kieffer, Timothy J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (12) : 1681 - 1692
  • [45] A role for central glucagon-like peptide-1 in temperature regulation
    OShea, D
    Gunn, I
    Chen, XH
    Bloom, S
    Herbert, J
    NEUROREPORT, 1996, 7 (03) : 830 - 832
  • [46] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [47] Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward
    Reddy, India A.
    Stanwood, Gregg D.
    Galli, Aurelio
    NEUROCHEMISTRY INTERNATIONAL, 2014, 73 : 49 - 55
  • [48] Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
    Knudsen, Lotte Bjerre
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2019, 2 (06) : 468 - 484
  • [49] The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
    Fang, Haowen
    Niu, Bing
    Chen, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2921 - 2943
  • [50] The complexity of signalling mediated by the glucagon-like peptide-1 receptor
    Fletcher, Madeleine M.
    Halls, Michelle L.
    Christopoulos, Arthur
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 582 - 588